This study looks at whether switching older adults (60+) with HIV from a three-drug pill (B/F/TAF) to a two-drug pill (DTG/3TC) is safe and keeps the virus under control. About 240 participants in Kenya will take the new pill for 96 weeks. The main goal is to see how many have de…
Phase: PHASE3 • Sponsor: University of Nairobi • Aim: Disease control
Last updated May 13, 2026 15:58 UTC